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b Veterans Affairs Health Care System, East Orange, Newark, NJ, United StatesThese Danish surgeons report outstanding 30-day
outcomes for carotid endarterectomy (CEA) in the
management of symptomatic carotid stenosis. Their review
is focused on 22 CEAs performed after thrombolysis for
cerebral ischemic attacks.1 The hypothetical question asked
is whether post-lytic candidates for CEA differ from those
with symptomatic extracranial carotid stenoses who did not
qualify for lysis. Is risk of CEA increased following lysis for
acute stroke?
The 90-day efﬁcacy of thrombolysis with the recombinant
tissue plasminogen activator alteplase (rt-PA) was reviewed
in a pooled analysis of US and European randomized
placebo controlled trials.2 Infusion of rt-PA is beneﬁcial
within 4.5 hours of stroke onset in appropriate individuals.
While one may quibble with the deﬁnition of stroke
requiring 24 hours, these studies excluded minor or
resolving neurological symptoms suggesting that transient
ischemic attacks were not treated with rt-PA during the
trials. It is unknown if indications for lysis have expanded
following its widespread introduction into clinical practice.
How often is extracranial carotid stenosis found following
rt-PA for acute strokes? Although their initial workup
routinely included a duplex ultrasound, the incidence of
carotid stenosis in the acute rt-PA population of their two
referring institutions is unknown. Likewise, the frequency of
carotid stenosis was not reported in the pooled trials vali-
dating rt-PA.2 The low incidence of 6% in Bartoli’s report is
substantially less than the 20-30% estimated by Rothwell.3
Treatment for acute cerebral attacks has focused on
intravenous rt-PA. In an effort to improve the limited
success of IV rt-PA, three recent trials randomized
concomitant aggressive, intracranial endovascular thera-
pies. No signiﬁcant beneﬁt beyond rt-PA was found.4
Bleeding is a major surgical concern. The 5 minute half-
life of alteplase is unlikely to affect an operative event
several days later. Aggressive antiplatelet therapy offers
potential for mischief in the OR. However, the unknown riskDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.02.020
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rt-PA requires a head CT to exclude hemorrhage; of note,
intracerebral hemorrhage following rt-PA was reported in
33%, but most were presumably asymptomatic.2 The one
reported morbidity resulting from CEA following rt-PA
therapy was attributed to hemorrhagic conversion; the
dramatic ﬁnding of a ﬂoating thrombus in conjunction with
a tight carotid stenosis following rt-PA therapy was the
rationale for CEA at 33 hours.3 Balancing this unknown risk
against the beneﬁts of CEA within a 2-week time frame may
be the essence of the question raised by this report. Strict,
intensive control of blood pressure is recommended to
decrease the risk of hyperperfusion syndrome.1e3
As lytic therapy for stroke becomes more common,
vascular surgeons throughout the world will be asked to
consider CEA in this setting. Since we really do not know
whether post-rt-PA patients are different from those with
stable strokes, and since recruitment of a sufﬁciently large
study group is daunting, a randomized trial is unlikely. Thus,
registry reports or additional reports like this are needed to
establish rational guidelines for surgical intervention. While
the numbers are small (N ¼ 49), the combined data pre-
sented here suggest that CEA may be beneﬁcial.REFERENCES
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